Aquilon Pharmaceuticals
PrivateLast Round
VC Round
Jun 3, 2025
Total Funding Raised
$10.35M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Aquilon Pharmaceuticals is a drug discovery company that develops pharmaceutical drugs for the treatment of pulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Aquilon Pharmaceuticals Comparables
Compare Aquilon Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Iconovo AB | 74% | |
| Transpire Bio Inc. | 73% | |
| Ligand Pharmaceuticals | 72% |
Aquilon Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Jun 3, 2025 | ||||
| Grant | Aug 1, 2023 | ||||
| Grant | Feb 1, 2022 | ||||
| Debt | May 11, 2021 | ||||
| VC Round | Nov 30, 2018 | ||||
Seed | Oct 26, 2015 |
Key People
Founding team and executive leadership
Aquilon Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Noshaq | VC Round |
| Wallonie Entreprendre | Grant |
| BioWin | Grant |
| Sambrinvest | VC Round |
| BeAngels | Seed, VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 886% MoM, reaching 2.7K.
- Feb 23, 2025
Monthly visitors increased 275% MoM.
Aquilon Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Aquilon Pharmaceuticals's valuation, stock price, and market status.
Is Aquilon Pharmaceuticals a public or private company?
Aquilon Pharmaceuticals is a private company.
What is the current stock price of Aquilon Pharmaceuticals?
Aquilon Pharmaceuticals is a private company with no public stock price. No recent secondary market data is available.
How much is Aquilon Pharmaceuticals worth (valuation)?
Valuation information for Aquilon Pharmaceuticals is not publicly available.
Can I buy Aquilon Pharmaceuticals stock?
Aquilon Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Aquilon Pharmaceuticals's last funding round?
Funding round information for Aquilon Pharmaceuticals is not publicly available.
Who are the main investors in Aquilon Pharmaceuticals?
Investor information for Aquilon Pharmaceuticals is not publicly disclosed.
Will Aquilon Pharmaceuticals IPO soon?
No public IPO plans have been announced for Aquilon Pharmaceuticals.
How can I track Aquilon Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Aquilon Pharmaceuticals's secondary market activity and sign up for updates.